Yong-Chang Zhang (Yongchang Zhang)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 48

Top Venues

Thoracic cancer

Cell death & disease

The Journal of experimental medicine

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Xing Zhang, Qinqin Xu, Yong-Chang Zhang
Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report. Thoracic cancer 15 (8) (2024)
Xing Zhang, Qinqin Xu, Yong-Chang Zhang
Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report. Thoracic cancer 15 (8) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Xing Zhang, Qinqin Xu, Yong-Chang Zhang
Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report. Thoracic cancer (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Xing Zhang, Qinqin Xu, Yong-Chang Zhang
Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report. Thoracic cancer 15 (8) (2024)
Min-Jiang Chen, Pengfei Ma, Yong-Chang Zhang, Dong Wang, Zhuang Yu, Yujie Fu, Xiaojing Zhao, Mengzhao Wang, Guanglei Zhuang, Ying Jing
Divergent tumor and immune cell reprogramming underlying immunotherapy response and immune-related adverse events in lung squamous cell carcinoma. Journal for immunotherapy of cancer 11 (10) (2023)
Nong Yang, Hai-Lin Yue, Bai-Hua Zhang, Juan Chen, Qian Chu, Jian-Xin Wang, Xiao-Ping Yu, Lian Jian, Ya-Wen Bin, Si-Ye Liu, Jin Liu, Liang Zeng, Hai-Yan Yang, Chun-Hua Zhou, Wen-Juan Jiang, Li Liu, Yong-Chang Zhang, Yi Xiong, Zhan Wang
Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB-III non-small cell lung cancer patients using radiomic features. Thoracic cancer (2023)
Zhe Huang, Huan Yan, Liang Zeng, Qinqin Xu, Wenhuan Guo, Shaoding Lin, Wenjuan Jiang, Zhan Wang, Li Deng, Haoyue Qin, Xing Zhang, Fan Tong, Ruiguang Zhang, Zhaoyi Liu, Lin Zhang, Xiaorong Dong, Nong Yang, Yong-Chang Zhang
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1 -Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study. JCO precision oncology 7 (2023)
Zhe Huang, Huan Yan, Liang Zeng, Qinqin Xu, Wenhuan Guo, Shaoding Lin, Wenjuan Jiang, Zhan Wang, Li Deng, Haoyue Qin, Xing Zhang, Fan Tong, Ruiguang Zhang, Zhaoyi Liu, Lin Zhang, Xiaorong Dong, Nong Yang, Yong-Chang Zhang
Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1 -Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study. JCO precision oncology 7 (2023)
Zhe Huang, Yong-Chang Zhang
Iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient. Thoracic cancer (2023)
Yuda Zhang, Fanxu Zeng, Shixuan Peng, Yangqian Chen, Wenjuan Jiang, Zhan Wang, Li Deng, Zhe Huang, Haoyue Qin, Huan Yan, Xing Zhang, Lin Zhang, Nong Yang, Qian Gong, Liang Zeng, Yong-Chang Zhang
Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics. Expert review of respiratory medicine (2023)
Zhe Huang, Yong-Chang Zhang
Iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient. Thoracic cancer 14 (8) (2023)
Xingxiang Pu, Chun-Wei Xu, Qian Wang, Wen-Xian Wang, Fang Wu, Xiuyu Cai, Zhengbo Song, Jinpu Yu, Wen-Zhao Zhong, Zhijie Wang, Yong-Chang Zhang, Jingjing Liu, Shi-Rong Zhang, Anwen Liu, Wen Li, Ping Zhan, Hongbing Liu, Tang-Feng Lv, Li-Yun Miao, Lingfeng Min, Gen Lin, Long Huang, Jingping Yuan, Zhansheng Jiang, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Xiaoyan Li, Chuanhao Tang, Cheng-Zhi Zhou, Junping Zhang, Hui Guo, Qian Chu, Rui Meng, Xuewen Liu, Jingxun Wu, Jin Zhou, Zhengfei Zhu, Weiwei Pan, Fei Pang, Jintao Huang, Kai Wang, Fan Wu, Tingting Shen, Shirui Zou, Bingwei Xu, Liping Wang, Youcai Zhu, Xinqing Lin, Jing Cai, Ling Xu, Jisheng Li, Xiaodong Jiao, Kainan Li, Huijing Feng, Lin Wang, Yingying Du, Wang Yao, Xuefei Shi, Xiaomin Niu, Dongmei Yuan, Yanwen Yao, Jing Kang, Jiatao Zhang, Chao Zhang, Jianfei Fu, Jianhui Huang, Yinbin Zhang, Pingli Sun, Hong Wang, Mingxiang Ye, Dong Wang, Zhaofeng Wang, Yue Hao, Zhen Wang, Bing Wan, Donglai Lv, Gang Lan, Shengjie Yang, Lin Shi, Yina Wang, Bihui Li, Zhang Zhang, Zhongwu Li, Yuan Li, Zhefeng Liu, Nong Yang, Huijuan Wang, Wenbin Huang, Zhuan Hong, Guansong Wang, Jiandong Wang, Meiyu Fang, Yong Fang, Xixu Zhu, Yi Shen, Yiping Zhang, Shenglin Ma, Yong Song, Yuanzhi Lu, Wenfeng Fang, Ziming Li, Lin Wu
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China. Thoracic cancer (2023)
Jie Zhao, Yayi He, Xue Yang, Panwen Tian, Liang Zeng, Kun Huang, Jing Zhao, Jiaqi Zhou, Yin Zhu, Qiyuan Wang, Mailin Chen, Wen Li, Yi Gao, Yong-Chang Zhang, Yang Xia
Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach. Journal for immunotherapy of cancer 11 (9) (2023)
Qian Wang, Chun-Wei Xu, Wen-Xian Wang, Yong-Chang Zhang, Ziming Li, Zhengbo Song, Jiandong Wang, Jinpu Yu, Jingjing Liu, Shi-Rong Zhang, Xiuyu Cai, Wen Li, Ping Zhan, Hongbing Liu, Tang-Feng Lv, Li-Yun Miao, Lingfeng Min, Jiancheng Li, Baogang Liu, Jingping Yuan, Zhansheng Jiang, Gen Lin, Xiaohui Chen, Xingxiang Pu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Xiaoyan Li, Chuanhao Tang, Cheng-Zhi Zhou, Junping Zhang, Hui Guo, Qian Chu, Rui Meng, Xuewen Liu, Jingxun Wu, Xiao Hu, Jin Zhou, Zhengfei Zhu, Xiaofeng Chen, Weiwei Pan, Fei Pang, Wenpan Zhang, Qijie Jian, Kai Wang, Liping Wang, Youcai Zhu, Guocai Yang, Xinqing Lin, Jing Cai, Huijing Feng, Lin Wang, Yingying Du, Wang Yao, Xuefei Shi, Xiaomin Niu, Dongmei Yuan, Yanwen Yao, Jianhui Huang, Xiaomin Wang, Yinbin Zhang, Pingli Sun, Hong Wang, Mingxiang Ye, Dong Wang, Zhaofeng Wang, Yue Hao, Zhen Wang, Bing Wan, Donglai Lv, Jianwei Yu, Jin Kang, Jiatao Zhang, Chao Zhang, Lixin Wu, Lin Shi, Leiguang Ye, Gaoming Wang, Yina Wang, Feng Gao, Jianfei Huang, Guifang Wang, Jianguo Wei, Long Huang, Bihui Li, Zhang Zhang, Zhongwu Li, Yueping Liu, Yuan Li, Zhefeng Liu, Nong Yang, Lin Wu, Qiming Wang, Wenbin Huang, Zhuan Hong, Guansong Wang, Fengli Qu, Meiyu Fang, Yong Fang, Xixu Zhu, Kaiqi Du, Jiansong Ji, Yi Shen, Jing Chen, Yiping Zhang, Shenglin Ma, Yuanzhi Lu, Yong Song, Anwen Liu, Wen-Zhao Zhong, Wenfeng Fang
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma. Thoracic cancer (2023)
Chun-Wei Xu, Yong-Chang Zhang, Wen-Xian Wang, Qian Wang, Ziming Li, Zhengbo Song, Jiandong Wang, Jinpu Yu, Jingjing Liu, Shi-Rong Zhang, Xiuyu Cai, Ming Wu, Ping Zhan, Hongbing Liu, Tangfeng Lv, Li-Yun Miao, Lingfeng Min, Jiancheng Li, Baogang Liu, Jingping Yuan, Zhansheng Jiang, Gen Lin, Xiaohui Chen, Xingxiang Pu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Xiaoyan Li, Chuanhao Tang, Cheng-Zhi Zhou, Junping Zhang, Hui Guo, Qian Chu, Rui Meng, Xuewen Liu, Jingxun Wu, Xiao Hu, Min Fang, Jin Zhou, Zhengfei Zhu, Xiaofeng Chen, Weiwei Pan, Fei Pang, Yuxiang Zhou, Qijie Jian, Kai Wang, Liping Wang, Youcai Zhu, Guocai Yang, Xinqing Lin, Jing Cai, Lijun Liang, Huijing Feng, Lin Wang, Yingying Du, Wang Yao, Xuefei Shi, Xiaomin Niu, Dongmei Yuan, Yanwen Yao, Jianhui Huang, Yinbin Zhang, Pingli Sun, Hong Wang, Mingxiang Ye, Dong Wang, Zhaofeng Wang, Yue Hao, Zhen Wang, Bing Wan, Donglai Lv, Genhua Yu, Anna Li, Jin Kang, Jiatao Zhang, Chao Zhang, Huafei Chen, Lin Shi, Leiguang Ye, Gaoming Wang, Yina Wang, Feng Gao, Wei Zhou, Chunxiu Hu, Jianguo Wei, Bihui Li, Zhongwu Li, Yuan Li, Zhefeng Liu, Nong Yang, Lin Wu, Qiming Wang, Wenbin Huang, Zhuan Hong, Guansong Wang, Meiyu Fang, Yong Fang, Xixu Zhu, Kaiqi Du, Jiansong Ji, Yi Shen, Yiping Zhang, Shenglin Ma, Yong Song, Yuanzhi Lu, Anwen Liu, Wenfeng Fang, Wen-Zhao Zhong
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors. Thoracic cancer (2023)
Zhe Huang, Yong-Chang Zhang
Iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient. Thoracic cancer 14 (8) (2023)
Zhe Huang, Yong-Chang Zhang
Iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient. Thoracic cancer 14 (8) (2023)
Chenglong Zhao, Jianghua Li, Yong-Chang Zhang, Rui Han, Yubo Wang, Li Li, Yimin Zhang, Mengxiao Zhu, Jie Zheng, Haiwei Du, Chen Hu, Cheng-Zhi Zhou, Nong Yang, Shangli Cai, Yong He
The rational application of liquid biopsy based on next-generation sequencing in advanced non-small cell lung cancer. Cancer medicine (2022)
Yue Hao, Gen Lin, Jing Xiang, Wen-Xian Wang, Chun-Wei Xu, Qian Wang, Jing Cai, Yong-Chang Zhang, Zhengbo Song
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients. Cancer medicine (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Lianxi Song, Liang Zeng, Huan Yan, Qinqin Xu, Qing Xia, Jian Lei, Xiaoyan Chen, Xiaoping Hu, Zhan Wang, Hong Liu, Nong Yang, Yong-Chang Zhang
Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer. Communications medicine 2 (1) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Lianxi Song, Liang Zeng, Yong-Chang Zhang
ALK-rearranged lung adenocarcinoma resistant to alectinib with cauliflower gingival metastasis responds to brigatinib. Thoracic cancer 13 (7) (2022)
Wen-Xian Wang, Qian Wang, Chun-Wei Xu, Ziming Li, Zhengbo Song, Yong-Chang Zhang, Xiuyu Cai, Shi-Rong Zhang, Bin Lian, Wen Li, Anwen Liu, Ping Zhan, Hongbing Liu, Tangfeng Lv, Li-Yun Miao, Lingfeng Min, Yu Chen, Jingping Yuan, Feng Wang, Zhansheng Jiang, Gen Lin, Xingxiang Pu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Xiaoyan Li, Chuanhao Tang, Cheng-Zhi Zhou, Congying Xie, Junping Zhang, Hui Guo, Qian Chu, Rui Meng, Jingxun Wu, Rui Zhang, Liping Wang, Youcai Zhu, Xiao Hu, Yanru Xie, Xinqing Lin, Jing Cai, Fen Lan, Huijing Feng, Lin Wang, Wang Yao, Xuefei Shi, Jianhui Huang, Huafei Chen, Yinbin Zhang, Pingli Sun, Bing Wan, Fei Pang, Zanmei Xu, Kai Wang, Yuanli Xia, Mingxiang Ye, Dong Wang, Qing Wei, Shuitu Feng, Jianya Zhou, Jiexia Zhang, Donglai Lv, Wenbin Gao, Jing Kang, Genhua Yu, Xianbin Liang, Chengtao Yu, Lin Shi, Nong Yang, Lin Wu, Zhuan Hong, Wei Hong, Meiyu Fang, Yiping Zhang, Yuanzhi Lu, Guansong Wang, Shenglin Ma, Lu Si, Wenfeng Fang, Yong Song
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor. Thoracic cancer 13 (23) (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Ying Jing, Yong-Chang Zhang, Jing Wang, Kunyan Li, Xue Chen, Jianfu Heng, Qian Gao, Youqiong Ye, Zhao Zhang, Yaoming Liu, Yanyan Lou, Steven Hsesheng Lin, Lixia Diao, Hong Liu, Xiang Chen, Gordon B Mills, Leng Han
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy. Journal of the National Cancer Institute 113 (10) (2022)
Shi-Rong Zhang, Wen-Xian Wang, Chun-Wei Xu, Yong-Chang Zhang, Xiuyu Cai, Qian Wang, Zhengbo Song, Ziming Li, Jinpu Yu, Wen-Zhao Zhong, Zhijie Wang, Jingjing Liu, Anwen Liu, Wen Li, Ping Zhan, Hongbing Liu, Tangfeng Lv, Li-Yun Miao, Lingfeng Min, Gen Lin, Long Huang, Jingping Yuan, Zhansheng Jiang, Xingxiang Pu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Xiaoyan Li, Chuanhao Tang, Cheng-Zhi Zhou, Junping Zhang, Hui Guo, Qian Chu, Rui Meng, Xuewen Liu, Jingxun Wu, Jin Zhou, Zhengfei Zhu, Weiwei Pan, Xiaowei Dong, Fei Pang, Kai Wang, Chao Yao, Guomin Lin, Site Li, Zhi Yang, Jiancheng Luo, Hongtao Jia, Xiuqing Nie, Liping Wang, Youcai Zhu, Xiao Hu, Yanru Xie, Xinqing Lin, Jing Cai, Yang Xia, Huijing Feng, Lin Wang, Yingying Du, Wang Yao, Xuefei Shi, Xiaomin Niu, Dongmei Yuan, Yanwen Yao, Jing Kang, Jiatao Zhang, Chao Zhang, Wenbin Gao, Jianhui Huang, Yinbin Zhang, Pingli Sun, Hong Wang, Mingxiang Ye, Dong Wang, Zhaofeng Wang, Bing Wan, Donglai Lv, Genhua Yu, Lin Shi, Yuanli Xia, Feng Gao, Xiaochen Zhang, Tao Xu, Wei Zhou, Haixia Wang, Zhefeng Liu, Nong Yang, Lin Wu, Qiming Wang, Guansong Wang, Zhuan Hong, Jiandong Wang, Meiyu Fang, Yong Fang, Yiping Zhang, Yong Song, Shenglin Ma, Wenfeng Fang, Yuanzhi Lu
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer. Thoracic cancer (2022)
Hui Li, Yong-Chang Zhang, Yanjun Xu, Zhiyu Huang, Guoping Cheng, Ming-Ying Xie, Zi-Chao Zhou, Yangyang Yu, Wenjing Xi, Yun Fan
Tumor immune microenvironment and immunotherapy efficacy in BRAF mutation non-small-cell lung cancer. Cell death & disease 13 (12) (2022)
Junjun Li, Yong-Chang Zhang, Li Wang, Min Li, Jianbo Yang, Pan Chen, Jie Zhu, Xiayu Li, Zhaoyang Zeng, Guiyuan Li, Zhaoyang Zeng, James B McCarthy, Bo Xiang, Mei Yi
FOXA1 prevents nutrients deprivation induced autophagic cell death through inducing loss of imprinting of IGF2 in lung adenocarcinoma. Cell death & disease 13 (8) (2022)
Chun-Wei Xu, Lu Si, Wen-Xian Wang, Ziming Li, Zhengbo Song, Qian Wang, Aijun Liu, Jinpu Yu, Wenfeng Fang, Wen-Zhao Zhong, Zhijie Wang, Yong-Chang Zhang, Jingjing Liu, Shi-Rong Zhang, Xiuyu Cai, Anwen Liu, Wen Li, Ping Zhan, Hongbing Liu, Tangfeng Lv, Li-Yun Miao, Lingfeng Min, Yu Chen, Jingping Yuan, Feng Wang, Zhansheng Jiang, Gen Lin, Xingxiang Pu, Rongbo Lin, Weifeng Liu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Lei Lei, Xiaoyan Li, Chuanhao Tang, Cheng-Zhi Zhou, Junping Zhang, Junli Xue, Hui Guo, Qian Chu, Rui Meng, Jingxun Wu, Rui Zhang, Xiao Hu, Jin Zhou, Zhengfei Zhu, Yongheng Li, Hong Qiu, Fan Xia, Yuanyuan Lu, Xiaofeng Chen, Rui Ge, Enyong Dai, Yu Han, Weiwei Pan, Jiancheng Luo, Hongtao Jia, Xiaowei Dong, Fei Pang, Kai Wang, Liping Wang, Youcai Zhu, Yanru Xie, Xinqing Lin, Jing Cai, Jia Wei, Fen Lan, Huijing Feng, Lin Wang, Yingying Du, Wang Yao, Xuefei Shi, Xiaomin Niu, Dongmei Yuan, Yanwen Yao, Jianhui Huang, Yinbin Zhang, Pingli Sun, Hong Wang, Mingxiang Ye, Dong Wang, Zhaofeng Wang, Bing Wan, Donglai Lv, Qing Wei, Jin Kang, Jiatao Zhang, Chao Zhang, Genhua Yu, Juanjuan Ou, Lin Shi, Zhongwu Li, Zhefeng Liu, Jing Liu, Nong Yang, Lin Wu, Huijuan Wang, Gu Jin, Liu Yang, Guansong Wang, Meiyu Fang, Yong Fang, Yuan Li, Xiaojia Wang, Yiping Zhang, Shenglin Ma, Biyun Wang, Xiaotian Zhang, Yong Song, Yuanzhi Lu
Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China. Thoracic cancer 13 (21) (2022)
Yong-Chang Zhang, Zhe Huang, Liang Zeng, Xiangyu Zhang, Yizhi Li, Qinqin Xu, Haiyan Yang, Analyn Lizaso, Chunwei Xu, Jun Liu, Wenxian Wang, Zhengbo Song, Sai-Hong Ignatius Ou, Nong Yang
Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements. NPJ precision oncology 6 (1) (2022)
Sk Kayum Alam, Yong-Chang Zhang, Li Wang, Zhu Zhu, Christina E Hernandez, Yuling Zhou, Nong Yang, Jian Lei, Xiaoyan Chen, Liang Zeng, Mark A Klein, Luke H Hoeppner
DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma. Oncogene (2021)
Jinye Mi, Qinqin Xu, Yong-Chang Zhang
Lung adenocarcinoma presents with diffuse bone metastasis. Thoracic cancer 12 (19) (2021)
Ling Peng, Kui Xiao, Jian Cui, Xiang-Hua Ye, Yong-Chang Zhang, Li Mao, Giovanni Selvaggi, Jennifer Yen, Justin Stebbing
Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLC. OncoTargets and therapy 14 (2021)
Ling Peng, Yong-Chang Zhang, Zibing Wang
Immune Responses against Disseminated Tumor Cells. Cancers 13 (11) (2021)
Xiangyu Zhang, Liang Zeng, Yizhi Li, Qinqin Xu, Haiyan Yang, Analyn Lizaso, Xinru Mao, Ren'an Jin, Yu Zeng, Qinglin Li, Jianbo Wang, Yang Li, Yong-Chang Zhang, Nong Yang
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China. Cancer immunology, immunotherapy : CII 70 (9) (2021)
Liang Zeng, Yizhi Li, Qinqin Xu, Wenjuan Jiang, Analyn Lizaso, Xinru Mao, Yong-Chang Zhang, Nong Yang, Zhenxing Wang
Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer. OncoTargets and therapy 13 (2020)
Liang Zeng, Qinqin Xu, Nong Yang, Analyn Lizaso, Yong-Chang Zhang
Third left pulmonary lobe. Thorax 76 (5) (2020)
Wei Wei, Jiao Zhou, Qun Zhang, De-Hua Liao, Qiao-Dan Liu, Bei-Long Zhong, Zi-Bin Liang, Yong-Chang Zhang, Rong Jiang, Gui-Yun Liu, Chen-Yang Xu, Huai- Li Zhou, Su-Yu Zhu, Nong Yang, Wen Jiang, Zhi-Gang Liu
Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study. Cancer medicine 9 (8) (2020)
Yijuan Hu, Lili Xiao, Nong Yang, Yong-Chang Zhang
Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patient. Thoracic cancer 10 (5) (2019)
Chen Xia, Fanxu Zeng, Yong-Chang Zhang
EGFR exon 21 L858R as an acquired resistance mechanism to nivolumab in a lung cancer patient originally driver gene-negative. Thoracic cancer 10 (5) (2019)
Zhongtai Wang, Hui Zhang, Chunhua Zhou, Xiaoyan Long, Rui Guan, Nong Yang, Yong-Chang Zhang
Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer. Cancer medicine 8 (4) (2019)

Yong-Chang Zhang.css-eqlu8i{font-size:small;padding-left:4px;} (Yongchang Zhang)

Publication Activity (10 Years)

Top Topics

Top Venues

Yong-Chang Zhang (Yongchang Zhang)